Kraig Biocraft Laboratories Ramps Full Production Across All Three Production Centers as Commercial Deliveries Begin to Take Hold
The first performance sportswear purchase order has been fulfilled, while staggered production schedules support supply for further commercial opportunities.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Kraig Biocraft Laboratories (OTCQB: KBLB) is running its September/October production cycle across all three centers following its first performance sportswear delivery. The company fulfilled that purchase order by shipping custom recombinant spider silk yarn to a globally recognized brand. Early reports indicate the current rearing cycle remains on track; it is not yet complete.
The centers use staggered schedules to maintain a steady supply of hybrid silkworm eggs for subsequent silk production and reduce reliance on a single facility. The current cycle focuses on parental strains, the breeding lines used to produce those eggs. Silk production grew more than 30% through the rainy season in the last production run. Management believes the phased production model helped deliver that result and positions operations to address additional commercial orders.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate pointSilk production grew more than 30% through the rainy season in the last production run.
- Minor pointFirst performance sportswear purchase order fulfilled, with custom recombinant spider silk yarn shipped to a globally recognized brand.
- Minor point. Forward-looking: it has not happened yet and may not happen.All three production centers are running on schedule; early reports indicate another successful rearing cycle is on track.
- Minor pointStaggered rearing schedules maintain hybrid egg supply and reduce reliance on any single facility.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Phased Production Model with Staggered Rearing Schedules Keeps Operations Running Continuously, Positioning Kraig Labs to Meet Future Commercial Demand
ANN ARBOR, Mich., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that its September/October production cycle is well underway, with all three production centers running. Early reports indicate the Company is on track for another successful rearing cycle.
The announcement comes just days after Kraig Labs fulfilled its first purchase order from the performance sportswear segment, shipping custom recombinant spider silk yarn to a globally recognized brand. That delivery marked the Company's transition from production milestones to commercial deliveries. This last cycle is further evidence of the production engine behind that milestone. Kraig Labs has built a reliable production platform capable of sustaining commercial-scale levels of spider silk to the market.
"Our team in Vietnam is executing well, and the early indicators for this cycle are encouraging," said Kim Thompson, Founder and CEO of Kraig Labs. "All three centers are up and running on schedule. That matters now, more than ever. We are no longer producing to demonstrate and confirm scale. Production is now focused on addressing the commercial market opportunities for spider silk."
Kraig Labs uses genetically engineered silkworms to produce silk containing key spider silk proteins. A “rearing cycle” involves raising a batch of silkworms from hatching through cocoon formation. The current cycle focuses on the Company’s parental strains, which are the breeding lines used to produce hybrid silkworm eggs. Silkworms hatched from those eggs subsequently produce the silk cocoons that are processed into yarn.
"Running three centers on phased schedules isn't just about volume," Thompson continued. "It's about building an operation that is resilient at high volume. One center can be in early rearing while another is deep into production and a third is preparing for harvest. That overlap gives us continuous output and real redundancy. If one center faces a disruption, the other two keep moving."
Kraig Labs' three production centers each run their own rearing cycle on a staggered schedule, so the facilities are at different stages of development at any given time. This approach maintains a steady supply of hybrid eggs for subsequent silk production while reducing reliance on any single facility.
That redundancy has taken on added significance following the Company's last production run. Kraig Labs grew silk production by more than
Thompson concluded, "A continuous, redundant production model is what positions Kraig Labs to move quickly when new opportunities arise. Three centers, three schedules, one continuous operation, prepared for the opportunities ahead."
The Company's leadership in biomaterials was recently spotlighted on the cover of the March 2026 issue of National Geographic, highlighting the growing importance and predominance of our work in scaling spider silk production.
Interested persons can order a copy of National Geographic featuring Kraig Labs at https://ngsingleissues.nationalgeographic.com/natgeo-march-2026.
You can purchase a digital copy of the article directly from National Geographic at https://www.nationalgeographic.com/science/article/spider-silk-silkworm-genetic-engineering
You can see Kraig Labs featured in Veritasium’s spider silk video at https://www.youtube.com/watch?v=wt4p2oalmRY
For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.
For details about recent Kraig Labs advancements, please watch the Company's investor updates at www.kraiglabs.com/videos or on the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
* For a description of our historical leadership in this technology, please follow this link https://www.kraiglabs.com/world-leader/
Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, Inc.
(720) 288-8495
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ab747743-744f-4ffd-bac0-9d6cad3dabec
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Has Kraig Biocraft Laboratories fulfilled its first performance sportswear order?
Kraig Biocraft Laboratories has fulfilled its first purchase order from the performance sportswear segment, shipping custom recombinant spider silk yarn to a globally recognized brand. The shipment marked its transition from production milestones to commercial deliveries.
What is the status of KBLB's September/October production cycle?
All three production centers are running on schedule, and early reports indicate the September/October rearing cycle is on track. The cycle focuses on parental strains used to produce hybrid silkworm eggs, which subsequently yield silkworms that produce silk cocoons for processing into yarn.